No results for ‘’
Aarti Pharmalabs Ltd
NSE: AARTIPHARM BSE: 543748
₹825.75
(0.47%)
Sun, 20 Sept 2026, 11:00 am
Market Cap (in Cr)7524.16
PE Ratio35.13
Dividend0.48
Health Technology
Pharmaceuticals: Major
24.5KCompany History
2019
- The Company was incorporated as a public limited company under the Companies Act, 2013.
2021
- The Company name was changed from Aarti Organics Limited to Aarti Pharmalabs Limited.
2022
- NCLT approved the Scheme of Arrangement between Aarti Industries Limited and Aarti Pharmalabs Limited.
- Pharma business of Aarti Industries Limited was vested into the Company.
2025
- Aarti Pharmalabs Ltd. Credit Rating was upgraded to CRISIL AA-/Stable.
- Aarti Pharmalabs earned an EcoVadis Gold Rating for sustainability.
- Aarti Pharmalabs achieved a key sustainability milestone with approval of GHG Emission Reduction Targets by SBTi.